Assessment of total silver and silver nanoparticle extraction from medical devices

Food and Chemical Toxicology

Volumn 85, Issue , 2015, Pages 10-19

  Sussman, Eric M ^a   Jayanti, Priyanka ^a,b   Dair, Benita J ^a   Casey, Brendan J ^a  

^a CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Exposure assessment; Extraction; Medical device; Silver nanoparticle

Indexed keywords

SILVER; SILVER NANOPARTICLE; SODIUM CHLORIDE; WATER; METAL NANOPARTICLE;

ANALYSIS; AQUEOUS DEVICE EXTRACT; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; EXTRACT; MASS SPECTROMETRY; MATERIAL COATING; MEDICAL DEVICE; MOLECULAR BIOLOGY; NANOPARTICLE TRACKING ANALYSIS; NONBIOLOGICAL MODEL; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PLASMA; RISK ASSESSMENT; RISK ASSESSMENT MODEL; SCANNING ELECTRON MICROSCOPY; SILVER RELEASE; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; ADVERSE EFFECTS; ATOMIC ABSORPTION SPECTROMETRY; BANDAGE; CATHETER; CHEMISTRY; COMPARATIVE STUDY; FLOW KINETICS; FOOD AND DRUG ADMINISTRATION; HUMAN; MATERIALS TESTING; PHOTOMETRY; SOLUBILITY; SPECTROPHOTOMETRY; SURFACE PROPERTY; ULTRASTRUCTURE; UNITED STATES;

BANDAGES; CATHETERS; HUMANS; MATERIALS TESTING; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; NEPHELOMETRY AND TURBIDIMETRY; PARTICLE SIZE; PLASMA; RHEOLOGY; RISK ASSESSMENT; SILVER; SODIUM CHLORIDE; SOLUBILITY; SPECTROPHOTOMETRY; SPECTROPHOTOMETRY, ATOMIC; SURFACE PROPERTIES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; WATER;

EID: 84958673244     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2015.08.013     Document Type: Article

References (44)

1. Benn T.M., Westerhoff P. Nanoparticle silver released into water from commercially available sock fabrics. Environ. Sci. Technol. 2008, 42:4133-4139. 10.1021/es7032718.
2. Benn T., Cavanagh B., Hristovski K., Posner J.D., Westerhoff P. The release of nanosilver from consumer products used in the home. J. Environ. Qual. 2010, 39:1875. 10.2134/jeq2009.0363.
3. Bressan E., Ferroni L., Gardin C., Rigo C., Stocchero M., Vindigni V., Cairns W., Zavan B. Silver nanoparticles and mitochondrial interaction. Int. J. Dent. 2013, 2013. 10.1155/2013/312747.
4. Busscher H.J., van der Mei H.C., Subbiahdoss G., Jutte P.C., van den Dungen J.J.A.M., Zaat S.A.J., Schultz M.J., Grainger D.W. Biomaterial-associated infection: locating the finish line in the race for the surface. Sci. Transl. Med. 2012, 4:153rv10. 10.1126/scitranslmed.3004528.
5. Chaloupka K., Malam Y., Seifalian A.M. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol. 2010, 28:580-588. 10.1016/j.tibtech.2010.07.006.
6. Chernousova S., Epple M. Silver as antibacterial agent: ion, nanoparticle, and metal. Angew. Chem. Int. Ed. 2013, 52:1636-1653. 10.1002/anie.201205923.
7. Chladek G., Kasperski J., Barszczewska-Rybarek I., Zmudzki J. Sorption, solubility, bond strength and hardness of denture soft lining incorporated with silver nanoparticles. Int. J. Mol. Sci. 2012, 14:563-574. 10.3390/ijms14010563.
8. Cortivo R., Vindigni V., Iacobellis L., Abatangelo G., Pinton P., Zavan B. Nanoscale particle therapies for wounds and ulcers. Nanomedicine in drug delivery 2010, 641-656.
9. Dair B.J., Saylor D.M., Cargal T.E., French G.R., Kennedy K.M., Casas R.S., Guyer J.E., Warren J.A., Kim C.-S., Pollack S.K. The effect of substrate material on silver nanoparticle antimicrobial efficacy. J. Nanosci. Nanotechnol. 2010, 10:8456-8462. 10.1166/jnn.2010.3566.
10. Echegoyen Y., Nerín C. Nanoparticle release from nano-silver antimicrobial food containers. Food Chem. Toxicol. 2013, 62:16-22. 10.1016/j.fct.2013.08.014.
11. Garcia-Reyero N., Kennedy A.J., Escalon B.L., Habib T., Laird J.G., Rawat A., Wiseman S., Hecker M., Denslow N., Steevens J.A., Perkins E.J. Differential effects and potential adverse outcomes of ionic silver and silver nanoparticles in vivo and in vitro. Environ. Sci. Technol. 2014, 48:4546-4555. 10.1021/es4042258.
12. Gee Kee E.L., Kimble R.M., Cuttle L., Khan A., Stockton K.A. n.d. Randomized controlled trial of three burns dressings for partial thickness burns in children. Burns. 2015 Aug, 41(5):946-955. (Epub 2015 Feb 14). 10.1016/j.burns.2014.11.005.
13. George R., Merten S., Wang T.T., Kennedy P., Maitz P. In vivo analysis of dermal and systemic absorption of silver nanoparticles through healthy human skin. Australas. J. Dermatol. 2013, 10.1111/ajd.12101.
14. Grunkemeier G.L., Jin R., Im K., Holubkov R., Kennard E.D., Schaff H.V. Time-related risk of the St. Jude Silzone heart valve. Eur. J. Cardiothorac. Surg. - Off. J. Eur. Assoc. Cardiothorac. Surg. 2006, 30:20-27. 10.1016/j.ejcts.2006.04.012.
15. Haase H., Fahmi A., Mahltig B. Impact of silver nanoparticles and silver ions on innate immune cells. J. Biomed. Nanotechnol. 2014, 10:1146-1156. 10.1166/jbn.2014.1784.
16. Haberl N., Hirn S., Wenk A., Diendorf J., Epple M., Johnston B.D., Krombach F., Kreyling W.G., Schleh C. Cytotoxic and proinflammatory effects of PVP-coated silver nanoparticles after intratracheal instillation in rats. Beilstein J. Nanotechnol. 2013, 4:933-940. 10.3762/bjnano.4.105.
17. Hadrup N., Lam H.R. Oral toxicity of silver ions, silver nanoparticles and colloidal silver - a review. Regul. Toxicol. Pharmacol. 2014, 68:1-7. 10.1016/j.yrtph.2013.11.002.
18. Holbrook R.D., Rykaczewski K., Staymates M.E. Dynamics of silver nanoparticle release from wound dressings revealed via in situ nanoscale imaging. J. Mater. Sci. Mater. Med. 2014, 25:2481-2489. 10.1007/s10856-014-5265-6.
19. Innes M.E., Umraw N., Fish J.S., Gomez M., Cartotto R.C. The use of silver coated dressings on donor site wounds: a prospective, controlled matched pair study. Burns 2001, 27:621-627. 10.1016/S0305-4179(01)00015-8.
20. Ip M., Lui S.L., Poon V.K.M., Lung I., Burd A. Antimicrobial activities of silver dressings: an in vitro comparison. J. Med. Microbiol. 2006, 55:59-63. 10.1099/jmm.0.46124-0.
21. Johnston H.J., Hutchison G., Christensen F.M., Peters S., Hankin S., Stone V. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit. Rev. Toxicol. 2010, 40:328-346. 10.3109/10408440903453074.
22. Kaewamatawong T., Banlunara W., Maneewattanapinyo P., Thammachareon C., Ekgasit S. Acute and subacute pulmonary toxicity caused by a single intratracheal instillation of colloidal silver nanoparticles in mice: pathobiological changes and metallothionein responses. J. Environ. Pathol. Toxicol. Oncol. - Off. Organ Int. Soc. Environ. Toxicol. Cancer 2014, 33:59-68.
23. Lankveld D.P.K., Oomen A.G., Krystek P., Neigh A., Troost-de Jong A., Noorlander C.W., Van Eijkeren J.C.H., Geertsma R.E., De Jong W.H. The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 2010, 31:8350-8361. 10.1016/j.biomaterials.2010.07.045.
24. Leaper D.J. Silver dressings: their role in wound management. Int. Wound J. 2006, 3:282-294. 10.1111/j.1742-481X.2006.00265.x.
25. Lee K.J., Nallathamby P.D., Browning L.M., Osgood C.J., Xu X.-H.N. In vivo imaging of transport and biocompatibility of single silver nanoparticles in early development of zebrafish embryos. ACS Nano 2007, 1:133-143. 10.1021/nn700048y.
26. Lee J.H., Kim Y.S., Song K.S., Ryu H.R., Sung J.H., Park J.D., Park H.M., Song N.W., Shin B.S., Marshak D., Ahn K., Lee J.E., Yu I.J. Biopersistence of silver nanoparticles in tissues from Sprague-Dawley rats. Part. Fibre Toxicol. 2013, 10:36. 10.1186/1743-8977-10-36.
27. Liu J., Murphy K.E., MacCuspie R.I., Winchester M.R. Capabilities of single particle inductively coupled plasma mass spectrometry for the size measurement of nanoparticles: a case study on gold nanoparticles. Anal. Chem. 2014, 86:3405-3414. 10.1021/ac403775a.
28. Mahmoud M.A., Chamanzar M., Adibi A., El-Sayed M.A. Effect of the dielectric constant of the surrounding medium and the substrate on the surface plasmon resonance spectrum and sensitivity factors of highly symmetric systems: silver nanocubes. J. Am. Chem. Soc. 2012, 134:6434-6442. 10.1021/ja300901e.
29. Maillard J.-Y., Hartemann P. Silver as an antimicrobial: facts and gaps in knowledge. Crit. Rev. Microbiol. 2012, 39:373-383. 10.3109/1040841X.2012.713323.
30. Mitrano D.M., Barber A., Bednar A., Westerhoff P., Higgins C.P., Ranville J.F. Silver nanoparticle characterization using single particle ICP-MS (SP-ICP-MS) and asymmetrical flow field flow fractionation ICP-MS (AF4-ICP-MS). J. Anal. At. Spectrom. 2012, 27:1131. 10.1039/c2ja30021d.
31. Monteiro D.R., Gorup L.F., Takamiya A.S., Ruvollo-Filho A.C., Camargo E.R.de, Barbosa D.B. The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver. Int. J. Antimicrob. Agents 2009, 34:103-110. 10.1016/j.ijantimicag.2009.01.017.
32. Monteiro D.R., Gorup L.F., Takamiya A.S., de Camargo E.R., Filho A.C.R., Barbosa D.B. Silver distribution and release from an antimicrobial denture base resin containing silver colloidal nanoparticles. J. Prosthodont. 2012, 21:7-15. 10.1111/j.1532-849X.2011.00772.x.
33. Munger M.A., Radwanski P., Hadlock G.C., Stoddard G., Shaaban A., Falconer J., Grainger D.W., Deering-Rice C.E. In vivo human time-exposure study of orally dosed commercial silver nanoparticles. Nanomedicine - Nanotechnol. Biol. Med. 2014, 10:1-9. 10.1016/j.nano.2013.06.010.
34. Park M.V.D.Z., Neigh A.M., Vermeulen J.P., la Fonteyne L.J.J.de, Verharen H.W., Briedé J.J., van Loveren H., de Jong W.H. The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials 2011, 32:9810-9817. 10.1016/j.biomaterials.2011.08.085.
35. Ramos K., Ramos L., Cámara C., Gómez-Gómez M.M. Characterization and quantification of silver nanoparticles in nutraceuticals and beverages by asymmetric flow field flow fractionation coupled with inductively coupled plasma mass spectrometry. J. Chromatogr. A 2014, 1371:227-236. 10.1016/j.chroma.2014.10.060.
36. Reidy B., Haase A., Luch A., Dawson K.A., Lynch I. Mechanisms of silver nanoparticle release, transformation and toxicity: a critical review of current knowledge and recommendations for future studies and applications. Materials 2013, 6:2295-2350. 10.3390/ma6062295.
37. Rigo C., Roman M., Munivrana I., Vindigni V., Azzena B., Barbante C., Cairns W.R.L. Characterization and evaluation of silver release from four different dressings used in burns care. Burns 2012, 38:1131-1142. 10.1016/j.burns.2012.06.013.
38. Rigo C., Ferroni L., Tocco I., Roman M., Munivrana I., Gardin C., Cairns W.R.L., Vindigni V., Azzena B., Barbante C., Zavan B. Active silver nanoparticles for wound healing. Int. J. Mol. Sci. 2013, 14:4817-4840. 10.3390/ijms14034817.
39. Sekine R., Brunetti G., Donner E., Khaksar M., Vasilev K., Jämting Å.K., Scheckel K.G., Kappen P., Zhang H., Lombi E. Speciation and lability of Ag-, AgCl-, and Ag2S-nanoparticles in Soil determined by X-ray absorption spectroscopy and diffusive gradients in thin films. Environ. Sci. Technol. 2014, 10.1021/es504229h.
40. Slane J., Vivanco J., Rose W., Ploeg H.-L., Squire M. Mechanical, material, and antimicrobial properties of acrylic bone cement impregnated with silver nanoparticles. Mater. Sci. Eng. C Mater. Biol. Appl. 2015, 48:188-196. 10.1016/j.msec.2014.11.068.
41. Srinivasan A., Karchmer T., Richards A., Song X., Perl T.M. A prospective trial of a novel, silicone-based, silver-coated foley catheter for the prevention of nosocomial urinary tract infections. Infect. Control Hosp. Epidemiol. 2006, 27:38-43. 10.1086/iche.2006.27.issue-1.
42. Stebounova L.V., Guio E., Grassian V.H. Silver nanoparticles in simulated biological media: a study of aggregation, sedimentation, and dissolution. J. Nanoparticle Res. 2010, 13:233-244. 10.1007/s11051-010-0022-3.
43. Wijnhoven S.W.P., Peijnenburg W.J.G.M., Herberts C.A., Hagens W.I., Oomen A.G., Heugens E.H.W., Roszek B., Bisschops J., Gosens I., Van De Meent D., Dekkers S., De Jong W.H., van Zijverden M., Sips A.J.A.M., Geertsma R.E. Nano-silver - a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 2009, 3:109-138. 10.1080/17435390902725914.
44. Zook J.M., MacCuspie R.I., Locascio L.E., Halter M.D., Elliott J.T. Stable nanoparticle aggregates/agglomerates of different sizes and the effect of their size on hemolytic cytotoxicity. Nanotoxicology 2011, 5:517-530. 10.3109/17435390.2010.536615.